TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Clearance rate of target AK
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Total AK clearance rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: self-reported shoulder pain and disability
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: PFDI-20 scores improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Objective recurrence rates
Endpoint domain: Adverse events/effects
Primary endpoint: Subjective vaginal bulge symptoms
Endpoint domain: Adverse events/effects
Primary endpoint: Driving pressure during surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of early postoperative pulmonary complications
Endpoint domain: Adverse events/effects
Primary endpoint: Growth Hormone (GH) index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Correct diagnosis of rejection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Correct decision on biopsy/transplant center referral
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Appropriate adjustment of therapeutic management
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in menopausal symptoms scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in depression symptoms scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Knee pain during stair navigation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: patient-oriented composite endpoint
Endpoint domain: Mortality/survival
Primary endpoint: device-oriented composite endpoint
Endpoint domain: Mortality/survival
Primary endpoint: Deficits in Social Functioning (SF)
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Deficits in Executive Functioning (EF)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in LV end-diastolic volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Risk of cardiovascular death or incident heart failure
Endpoint domain: Mortality/survival
Primary endpoint: Bioavailability of AMPH ER TAB
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peak exposure (Cmax) of d-amphetamine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peak exposure (Cmax) of l-amphetamine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cognitive performance (Stroop color-word interference)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Successful revascularization rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Time from groin puncture to maximal revascularization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Implementation costs per participant who made a clinic appointment
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Implementation costs per participant who completed screening
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: NEI score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TBUT score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 2-hour pruritus score change from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean time spent in treatment center
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Adolescent pregnancy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Adherence to Antiretroviral and Antihypertensive Medications
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in BEmONC clinical skills
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Best Spectacle-Corrected Visual Acuity (BSCVA) at 3 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Scar surface texture
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Recurrent stroke within 90 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Mean time of tibial bone union
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Likelihood of transfusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: WMFT-Time scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Social trust
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Norm of reciprocity
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: aortic root z score change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Site infestation rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of T. cruzi infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Infected-bug abundance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tumor-to-background ratio for 18F-4FMFES
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Cmax geometric mean ratio for BIC/TAF/FTC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC geometric mean ratio for BIC/TAF/FTC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SMPR achievement rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 12-month PSA response rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mite survival rate
Endpoint domain: Mortality/survival
Primary endpoint: Nasal blockage score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Difficulty in sense of smell score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean stress reduction
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Requirement for further surgery
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: RCMFE of the CP signal
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: increased functional connectivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Montgomery-Asberg Depression scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recognition of breathing patterns
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: statistically significant improvement at the primary endpoint
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Knowledge Scale Score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Attitude Scale Score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: coupling strength with the amygdala
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: warmth perception of the feet
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Prevalence of dry eye
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cell survival rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Jurkat cell apoptosis rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Correlation between SAM68 and sFLT1 expression levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Correlation between SAM68 and FLT1 expression levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perinatal 25(OH)D status
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: reduction in absolute noninflammatory lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reduction in inflammatory lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: User acceptance
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Usability level of the TK
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Objectively measured use of the TK
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HCV screening completion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: balance and gait improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: NRS score at 24 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Use of oral morphine equivalents
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to alleviation of all COVID‐19‐related symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Subsequent emergency department visits or hospital admissions for COVID‐19
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Number of days without diarrhea
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: ameliorate osteoarthritic pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: promote physical function
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: promote quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: plasma glucose concentration 2 h after a 75-g glucose load
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Frequency of overuse tests
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Fungal clearance from cerebrospinal fluid
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total LKES score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: graft success rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Hospitalization due to GBS
Endpoint domain: Adverse events/effects
Primary endpoint: Death due to GBS
Endpoint domain: Mortality/survival
Primary endpoint: increases in anxiety, anger, and disgust
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: distress across the duration of the recording
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Catastrophic costs experienced by TB affected households
Endpoint domain: Resource use
Endpoint subdomain: Societal/carer burden
Primary endpoint: Reduction of contracture
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Achievement of individual functional goals
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Voice handicap index score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean time for leveling and alignment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean alignment improvement percentage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Parents' mean satisfaction with the e-learning program
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Concentration of [14C]-resveratrol species in prostate tissue
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prostate cell numbers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean number of interventions
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Proportion of patients maintaining therapeutic response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of warts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Size of the largest wart
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Microbial reduction efficacy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Probability of reaching the FSG target without hypoglycemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Proportion of patients achieving the 26-week endpoint
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: gain score in leadership evaluation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Alanine aminotransferase concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Twitch airway pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Decision Conflict Score (DCS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Knowledge Scores
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: grief severity
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Homogeneity Index (HI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prescription dose coverage of target volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: exercise motivation
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Sensitivity of FIT for colorectal cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Positive predictive value for colorectal cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in neck disability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: duration of invasive mechanical ventilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: neonatal composite outcome
Endpoint domain: Adverse events/effects
Primary endpoint: NICU admission
Endpoint domain: Adverse events/effects
Primary endpoint: Coping process scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: persistence rate of active surveillance
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: number of positive cores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: prostate volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Average time spent in cast
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Identification of Candida species
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: mean daily time spent in NSPA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean time spent in MVPA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Central venous catheter‐associated deep venous thrombosis risk ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Percentage of patients with a CRP PMR-AS score less than 10
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of patients no longer receiving prednisone
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cannabis craving
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean latency time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: mean threshold
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: mean depolarization rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: in-study vaccination rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Amygdala-VLPFC connectivity change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease in parathormone (PTH) levels by 30%
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PNI (Prognostic Nutritional Index)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease in smoking rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percentage of sealer penetration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: gap width
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: uremic toxins plasma levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Overall survival (OS) rates at 48 months
Endpoint domain: Mortality/survival
Primary endpoint: MOFQ-Pain subscale score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HIPA angle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IMA angle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Probability of developing parasitemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Total Arterial Compliance (TA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Parturient satisfaction scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Postoperative sensory level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Conspicuity of calcifications
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Conspicuity of architectural distortion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: intended behaviour
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: illness-related misconceptions
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: stereotype endorsement
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Reduction in SSB intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: levels of sexual assault and forced sex
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: QOL physical impact
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Serum ADA level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: %Time in Range (TIR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mean sensor glucose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Rate of unplanned infusion set changes due to infusion site reactions
Endpoint domain: Adverse events/effects
Primary endpoint: U1 retroclination
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: U1 distal movement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hand motor function improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Participant adherence to the intervention
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Narcotic pill consumption
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: percentage changes in seizure rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Mean FEV1 decrease after cold air exercise challenge
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: eNO levels after 4 weeks sc-LCPUFA supplementation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Downsizing to resection/ablation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Increase in blood monounsaturated fatty acid levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Increase in BAT activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase in leptin concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Proportion of institutional births
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Associative Learning Test (ALT) performance
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: ASD severity correlated with SpCO
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: effective rate of CDCQD group
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: recovery time of exhaust and defecation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: daily drainage volume of TIT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes